The landscape of ROS1 fusion in patients with non-small cell lung cancer in China

被引：0
|
作者：
Chen, M. [1 ]
Huang, D. [2 ]
She, X. [2 ]
Shen, X. [2 ]
Zhang, H. [2 ]
Luo, Z. [3 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 3, Dept Resp, Chongqing, Peoples R China
[2] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1722
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1408P
引用
收藏
页码：S891 / S891
页数：1
相关论文
共 50 条
  • [1] Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer
    Zhang, Qing
    Wu, Chunyan
    Ding, Wei
    Zhang, Zhihong
    Qiu, Xueshan
    Mu, Dianbin
    Zhang, Haiqing
    Xi, Yanfeng
    Zhou, Jianhua
    Ma, Liheng
    Fu, Shijun
    Gao, Min
    Wang, Bo
    Deng, Juan
    Lin, Dongmei
    Zhang, Jie
    THORACIC CANCER, 2019, 10 (01) : 47 - 53
  • [2] Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion-driven non-small cell lung cancer
    Desilets, Antoine
    Repetto, Matteo
    Drilon, Alexander
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (10):
  • [3] The routine detection of ROS1 fusion rearrangement in non-small cell lung cancer
    Wu, J.
    Lin, Y.
    He, X.
    He, P.
    Fu, X.
    Gu, X.
    ANNALS OF ONCOLOGY, 2015, 26 : 9 - 9
  • [4] ROS1 FUSION GENES: POTENTIAL DRUG TARGETS IN NON-SMALL CELL LUNG CANCER
    Davies, Kurtis D.
    Le, Anh T.
    Theodoro, Mariana F.
    Skokan, Margaret C.
    Aisner, Dara L.
    Terracciano, Luigi M.
    Incarbone, Matteo
    Roncalli, Massimo
    Cappuzzo, Federico
    Camidge, Ross D.
    Doebele, Robert C.
    Garcia, Marileila V.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S146 - S146
  • [5] Zeroing in on ROS1 Rearrangements in Non-Small Cell Lung Cancer
    Stumpfova, Magda
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4222 - 4224
  • [6] Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
    Itchins, M.
    Alexander, M.
    John, T.
    Kao, S.
    Hughes, B.
    Hayes, S.
    Howel, V.
    Harvie, R.
    Clarke, S.
    Millward, M.
    Pavlakis, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S684 - S684
  • [7] ROS1 immunocytochemistry on cytological specimens in patients with non-small cell lung cancer
    Vlajnic, T.
    Savic, S.
    Bubendorf, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Clinicopathological significance and diagnostic approach of ROS1 rearrangement in non-small cell lung cancer: a meta-analysis: ROS1 in non-small cell lung cancer
    Yang, Jungho
    Pyo, Jung-Soo
    Kang, Guhyun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04): : 520 - 527
  • [9] Resistance to lorlatinib in ROS1 fusion-positive non-small cell lung cancer.
    Lin, Jessica Jiyeong
    Johnson, Ted
    Lennerz, Jochen K.
    Lee, Charlotte
    Hubbeling, Harper Grace
    Yeap, Beow Y.
    Dagogo-Jack, Ibiayi
    Gainor, Justin F.
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Clinicopathologic characteristics of patients with ROS1 fusion gene in non-small cell lung cancer: a meta-analysis
    Zhu, Qingqing
    Zhan, Ping
    Zhang, Xinlin
    Lv, Tangfeng
    Song, Yong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (03) : 300 - 309
12345